Examination about BD NexivaTM closed IV Catheter System of use in peripheral intravenous or intra-arterial cannulation.

Examination about BD NexivaTM closed IV Catheter System of use in peripheral intravenous or intra-arterial cannulation. - Examination about BD NexivaTM closed IV Catheter System of use in peripheral intravenous or intra-arterial cannulation.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000013420

Enrollment

Registered

2014-03-15

Start date

2014-03-15

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

The patients aged 20-85 years old, who were ASA-PS 1-3.

Interventions

BD Nexiva TM . Surshield Surflo II.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients who were scheduled for elective surgery ,and who were ASA-PS 1-3.

Exclusion criteria

Exclusion criteria: Patients who were diagnosed arteriosclerotic disease ( coronary artery disease, cerebrovascular disease, arteriosclerosis obliterans, etc.).

Design outcomes

Primary

Measure	Time frame
Primary outcomes were the number of blood exposures for cannulation, and the number of attempts at insertion of the cannula.	—

Countries

Japan

Contacts

Public ContactSatoshi Tanaka

Shinshu University School of Medicine Department of Anesthesiology and Resuscitology

s_tanaka@shinshu-u.ac.jp0263-37-2670

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026